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A compIementa~ DNA encoding an amiloride-~nsitive Na’ channel has been cloned and characterized from rat colon. The protein encoded by 
the cDNA has a sequence of 699 amino acids (79 kDa) containing several putative membrane spanmng domains and potential phospho~lation 
sites. It forms a channel that has the el~trophysiological and pha~acological properties characteristic of the epithelial Na+ channel. Homologies 
(including in transmembran~ domains) have been found between a part of the channel sequence and the Mec4 gene product of Cffe~or~~~~~f~~ 
efegans, a protein associated with mutation-induct neuronal degeneration. 
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1. INTRODUCTION 
Amilorid~-sensitive Na’ channels have an important 
role in sodium and water homeostasis. They are present 
on the apical membrane of kidney, lung and descending 
colon cells and in other epithelia~ tissues (reviewed in 
refs. 1 and 2). These channels are also present in blood- 
brain barrier endothelial cells [3] and have a role in 
sensory perception 12.41. Amiloride, the typical blocker 
of this type of channel, is a classical diuretic used in the 
treatment of hypertension and of a potential use in the 
treatment of cystic fibrosis [S]. 
The molecular structure of the amiloride-sensitive 
Na” channel is still unknown. Purifications of epithelial 
Na’ channels from different sources have been reported 
[6,7] and two potential candidates have been cloned 
[8,9]. One of them from human kidney ]8] is a - 100 
kDa amiloride binding protein which after transfection 
into mammalian cells displays a pharmacology similar 
to that of Na’ channels but does not express Na’ chan- 
nel activity. Another one, which is present in Xenopus 
Levis tissues, has a N, of 160 kDa but although it is 
recognized by antibodies thought to bind to the amilo- 
ride receptor site, does not display Na’ channel activity 
]91* 
Rat distal colon is a particularly interesting starting 
material to isolate a cDNA for the amiloride-sensitive 
Na’ channel since very high expression levels of that 
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channel are induced by aldosterone (or dexamethasone) 
[2,10,11]. 
This paper reports the cloning of the rat colon amilo- 
ride-sensitive Na’ channel by expression in Xenopus 
oocytes. 
2. MATERIALS AND METHODS 
2.1. RNA preparation 
Wistar rats were infused once a day during 3 days with 3 mg 
dexamethasone in corn oil and sacrificed the fourth day. Total RNA 
was extracted from the epithelium of distal colon by the lithium chlo- 
ride method [12]. To obtain poly(A’) RNA, total RNA was loaded on 
an oligo(dT) cellulose column in Tris-HCI 10 mM at pH 7.5, EDTA 
1 mM, NaCl 0.5 M, SDS 0.11, eluted with water, and precipitated. 
2.2. cDNA library synthesis and screening 
A size-selected irectional cDNA library was synthesized from the 
rat colon mRNA using a modification of ]l3]. 
An oligo(dT)-~~~1 primer-adapter was used to prime first strand 
cDNA synthesis which was performed in the presence of S-methyl 
dCTP to protect internal XhoI sites. After synthesis of double- 
stranded cDNA, EcoRI adaptors were added and the cDNA was cut 
with XhoI. The resulting cDNA was size fractionated on Sephacryl 
SIOOQ and cDNAs greater than 2 kb were ligated into the EcQRIlXhoI 
sites of the cloning vector pEX0. 
The pEX0 vector was derived from pGEM 5-Zf(-) (Promega) by 
inserting the 5’- and 3’untranslated regions of Xenopus globin f14] 
which flank an EcuRIIXhoI polylinker into the EcoRV site. A T7 
terminator was ligated into the Sac1 and the NdeI sites of the vector 
and ATG sequences downstr~m of the T7 promoter were removed 
by digestion with Neof and SphI followed by blunt end religation. The 
E. colt strain SURE (Stratagene) was transformed with the cDNA 
library by electroporation. 
The 100 000 recombinants obtained were subdivided in 20 subpools 
of 5,000 and plated on Hybone-N filters. After an overnight growth at 
30°C. replicas were made and the template filters were frozen [15]. The 
replicas were grown again at 37*C, bacteria were scraped off and 
plasmid was prepared using the alkaline lysis technique. 
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Fig. I. Electrophysiological and pharmacological ch racterization f the RCNaCh in Xenopus oocytes. A. I-Vrelationship of the amiloride-sensitive 
Na+ channel expressed from rat colon poly(A’) RNA in a Na’ medium (4 days after injection). B. I-V relationship for RCNaCh cRNA injected 
oocytes (2 days after injection) in a Li’ medium (a) and in a Na+ medium (0). C. Reversible ffect of 20pM amiloride on RCNaCh cRNA expression 
(24 h after injection). The control corresponds to an oocyte injected with the same cRNA, one hour after injection, i.e. a time too short to produce 
Na’ channel expression. Results similar to those in the control were obtained with water-injected or uninjected oocytes. D. Dose-response curves 
for amiloride and amiloride derivatives, phenamil (m) (n = 2), amdoride (0) (n = 4) and ethylpropylamiloride (0) (n = 3). Voltage was clamped at 
-70 mV. 
In vitro transcription was performed with NotI-linearized DNA 
using a Stratagene kit with T7 RNA polymerase. Capped cRNAs (at 
1 &~l) were injected into oocytes (50 nl/egg). After 3 days, the oocytes 
were tested by “Na’ flux measurements with and without amlloride 
10 PM as described in [16] and by electrophysiology (measuring the 
amiloride (20 PM) sensitive component of the whole egg current). 
The frozen filter of the positive fraction was cut into parts and the 
whole process was repeated until a single positive clone was Identified. 
2.3. Characterization of the clone 
The 3081 nucleotide cDNA Insert was sequenced m both directions 
by dideoxy sequencing [ 171 using the dye terminator kit and automatic 
sequencing (Applied Biosystems 373A). DNA for sequencing was 
prepared with the Erase-A-Base system from Promega. 
2.4. Oocyte preparatron, microinJection. eiectrophqmoiogical measure- 
ments 
They were carried as described in [ 181. For measurement of current- 
voltage relationships, the clamping voltage was changed in steps from 
a holding potential of -70 mV and held at the test voltages for l-2 s. 
2.5. In vrtro translation 
In vitro translation was carried out in the presence of [35S]methion- 
ine with a reticulocyte lysate (Promega) according to the supplier 
protocol. For maturation studies. 2.5 ,~1 of canine pancreatic mem- 
branes per 25 ~1 final volume were used. p-Lactamase and the cc-factor 
were used to control the signal peptide cleavage and glycosylation 
respectively. In vitro translation products were analyzed by SDS- 
PAGE and revealed by autoradiography. 
3. RESULTS AND DISCUSSION 
Amiloride-sensitive Na’ channels have been previ- 
ously expressed in Xenopus oocytes from poly(A)’ RNA 
96 
from different tissues [ 16,191. These expression studies 
have led to a M, weight prediction of 70-80 kDa for the 
channel protein [19]. Our cloning strategy has used the 
oocyte expression system and two independent meas- 
urements of the Na’ channel activity involving electro- 
physiology and ‘2Na* uptake experiments. Distal rat 
colon samples expressing amiloride-sensitive short cir- 
cuit currents higher than 500 ,&Jcm’ were selected for 
poly(A)’ RNA isolation. A rat cDNA library was then 
constructed in an expression vector from a high re- 
sponse-evoking sample. A single channel cDNA clone 
(called RCNaCh for rat colon Na’ channel) was iso- 
lated by serially subdividing the positive cDNA mix- 
tures. 
The electrophysiological properties of the cloned 
amiloride-sensitive RCNaCh are presented in Fig. 1. 
This figure shows that I-V relationships obtained with 
poly(A)’ RNA (Fig. 1 A) and cRNA (Fig. 1 B) are very 
similar. These responses are also similar to those ob- 
served with poly(A’) RNA from other tissues [2,19]. 
The cloned Na’ channel, like the channel in intact cells 
[2], has been found to be permeable to both Na’ and Li’ 
(Fig. 1 B), with I,,/&, = 1.6 at -70 mV. 
An important aspect of epithelial Na’ channels is 
their sensitivity to amiloride. Amiloride derivatives 
have been developed which can discriminate between 
the Na’ channel and Na’/H’ or Na’/Ca” exchangers 
[20,21]. Phenamil has a high affinity for Na’ channels 
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AFPHPL*RLRTPPPPYSGRTARSGSSSVRD 240 
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aaaaaaaa 3028 
Fig. 2. cDNA and deduced amino acid sequence of RCNaCh. 
and a poor affinity for Na’/H’ and Na’/Ca” exchang- 
ers. It is considered to be the most specific blocker of 
the Na’ channel 1211. On the other hand ethylpropyl- 
amiloride is known to be a potent blocker of the Na’/H’ 
exchanger and a very weak effector of the Na’ channel 
[21]. Amiloride reversibly blocks Na’ channel activity 
from oocytes injected with the cRNA (Fig. 1C). Dose- 
response curves for the inhibition of the Na+ channel 
activity of the cloned protein by amiloride and deriva- 
tives are presented in Fig. 1D. ED,,‘s are 44 nM, 620 
nM, and >300 ,uM for phenamil, amiloride and eth- 
ylpropylamiloride, respectively. These values are very 
similar to those previously described for the native 
channel in colon of dexamethasone-treated rats [22]. 
The nucleotide sequence of the cloned cDNA (3081 
bp) is presented in Fig. 2. It contains one open reading 
frame of 2097 base pairs (bp). The predicted polypep- 
tide consists of 699 amino acids. The calculated molec- 
ular weight of 79 kDa is in good agreement with results 
from in vitro translation experiments (Fig. 3, lanes a 
and b), which produced in the absence of microsomal 
membranes a polypeptide with an apparent molecular 
weight of 75 kDa in SDS-PAGE. The apparent M, in- 
creased to 92 kDa (Fig. 3, lane c) when translation was 
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Fig. 3. Electrophoresis pattern of in vitro translatton products of the 
Na’ channel cRNA. M, (kDa) are shown on left. Lane a, cRNA with 
reticulocyte lysate; lane b, same condrtions wtth 0.5% ofTriton X-100; 
lane c, cRNA with reticulocyte lysate and canine pancreatic micro- 
somes; lane d. control cRNAs for a-factor and/Mactamase with retic- 
ulocyte lysate and pancreatic mtcrosomes. 
carried out in the presence of microsomal membranes, 
suggesting a maturation process probably associated 
with glycosylation. 
A hydrophobicity analysis of RCNaCh showed the 
presence of four main hydrophobic domains consisting 
of more than 20 amino acids residues (Fig. 4B). Two of 
these domains from 110 to 162 and from 567 to 613 are 
sufficiently long to be split into 2 transmembrane seg- 
ments. Therefore we have tentatively built a model (Fig. 
4A) which presents 6 transmembrane regions. Since 
there is no signal peptide, the N-terminal end of the 
channel was assumed to be cytoplasmic. The main ex- 
tracellular loop from 378 to 566 contains 2 N-glycosyl- 
ation sites in positions 425 and 539 (the other potential 
N-glycosylation sites are not indicated in this model 
because they are situated on intracellular segments). 
Two potential consensus phosphorylation sites for 
kinase A have been identified at Ser-204 and Ser-205 as 
well as 8 consensus ites for phosphorylation by kinase 
C and 8 sites for casein kinase II (Fig. 4A). Therefore 
multiple types of regulations of this channel protein are 
theoretically possible and might account for the well 
known hormonal regulation of the channel [1,2]. 
The Na’ channel protein shows no significant se- 
quence homology with other previously cloned channels 
(including the voltage-sensitive Na’ channel). A partic- 
ularly interesting sequence homology has been found 
in 
6 
between RCNaCh and the Mec4 gene product from 
C. elegans which has been called a degenerin [23], a 
transmembrane protein whose mutation provokes neu- 
ronal degeneration. Sequence homologies between 
Mec4 (a 497 amino acids segment) and the 127 to 638 
region of RCNaCh are presented in Fig. 5. This se- 
quence homology suggests that, as previously discussed 
[23], Mec4 degenerin might be an ionic channel which 
could be speculated to be a non selective channel or a 
new type of Cal+ channel both capable to introduce 
deleterious concentrations of Ca’+ into cells. It is partic- 
ularly interesting to note that on one hand Mec4 is 
associated with touch cells that are required for mecha- 
nosensation [23] while, on the other hand, mechanosen- 
sitive channels are blocked by high concentrations of 
amiloride [24]. 
In conclusion amiloride-sensitive Na’ channel activ- 
ity is generated by a single protein of 79 kDa which 
seems to have most or all of the biophysical and phar- 
macological properties of the native channel in the ep- 
ithelial tissue. However, one cannot eliminate that other 
types of subunits associate to this channel protein for 
regulation of its activity, as observed for most voltage- 
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Fig. 4. (A) A putative structural model of the amiloride-sensitive Na’ 
channel. (B) Hydrophobtcity plot according to [25] using a window of 
15 amino actds. Hydrophobic segments are presented m black. 
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Fig. 5. Protein sequence homology between RCNaCh and the known sequence of Med degenerin. Identical amino acids are labelled in black, and 
amino acids with similar side chains are in grey. 
sensitive channels. The structure described here is that 
of a new channel type which seems to include degenerins 
and might also include many other ionic channels that 
have been identified electrophysiologically but not yet 
cloned. 
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